0001966774

IPO filing research

EIR Biopharma, Inc.

Biological Products, (No Diagnostic Substances)

ipo filed S-1

EIR Biopharma, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-02-17.

Filing Timeline

SEC EDGAR

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

First tracked pre-IPO filing for this issuer.

The filing appears to be a placeholder or incomplete data extract with no substantive narrative content. The document contains technical metadata, financial line items, and references to investors and licensing agreements but lacks a coherent description of the company's business, offerings, or IPO details.

2026-02-17 · 0001520138-26-000057

Comparable Deals

14 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 14 using nearest neighbors.

Showing top 8 by similarity.

-0.3%

Median day-1

50%

Above issue

-3.0%

Median week-1

-20.9%

Downside (p10)

Odyssey Therapeutics, Inc. ODTX

2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%

same SICrecent IPO

Hemab Therapeutics Holdings, Inc. COAG

2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%

same SICrecent IPO

Agomab Therapeutics NV AGMB

2026-02-06 $200M Day 1: -8.4% Wk 1: -2.1%

same SICrecent IPO

Eikon Therapeutics, Inc. EIKN

2026-02-05 $381M Day 1: -16.7% Wk 1: -19.5%

same SICrecent IPO

Seaport Therapeutics, Inc. SPTX

2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%

same SIC grouprecent IPO

Avalyn Pharma Inc. AVLN

2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%

same SIC grouprecent IPO

First Tracks Biotherapeutics, Inc. TRAX

2026-04-20 - Day 1: -9.3% Wk 1: -11.5%

same SIC grouprecent IPO

Kailera Therapeutics, Inc. KLRA

2026-04-17 $625M Day 1: +62.5% Wk 1: +56.7%

same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.